Fasciotomy Market Size, Share, Industry, Forecast and outlook (2024-2031)

Report Overview

The Global Fasciotomy Market reached US$ 4.15 billion in 2023 and is expected to reach US$ 6.68 billion by 2031, growing at a CAGR of 6.3% during the forecast period 2024-2031.

Fasciotomy is a surgical procedure where the fascia is cut to relieve tension or pressure to treat the resulting loss of circulation to an area of tissue or muscle. Fasciotomy is a limb-saving procedure when used to treat acute compartment syndrome. It is also sometimes used to treat chronic compartment stress syndrome. The procedure has a very high rate of success, with the most common problem being accidental damage to a nearby nerve.

Before the procedure, doctors administer regional or general anesthesia. The surgeon makes an incision above the affected muscle compartment, opening the restrictive fascia—thick sheets of connective tissue—to relieve pressure and increase blood flow to muscles and nerves. More than one incision may be required if multiple muscles are affected.

Market Scope

For more details on this report - Request for Sample

Market Dynamics: Drivers

Increasing prevalence of compartment syndrome

The demand for the global fasciotomy market is driven by multiple factors. The rising prevalence of compartment syndrome propels the market growth. 

Furthermore, the demand for treatment will be fueled by technological advancements. For instance, according to nih.gov, The incidence of acute compartment syndrome is estimated to be 7.3 per 100,000 in males and 0.7 per 100,000 in females, with the majority of cases occurring after trauma. Tibial shaft fracture is the most common cause of acute compartment syndrome and is associated with a 1 to 10 percent incidence of acute compartment syndrome.

Acute compartment syndrome occurs more commonly in males younger than 35, which may be due to a larger relative intracompartmental muscle mass and increased likelihood of being involved in high-energy trauma. Patients with bleeding diathesis, such as hemophilia, are at greater risk for acute compartment syndrome. Cases of acute compartment syndrome have been reported without acute precipitating trauma in pediatric leukemia. 

Restraints

Factors such as high costs associated with the procedure and stringent regulatory requirements for the approval of new treatments are expected to hamper the market.

Market Segment Analysis

The global fasciotomy market is segmented based on type, application, end-user, and region.

The segment skin graft fasciotomy instrument (STSG) accounted for approximately 58% of the global fasciotomy market share

The skin graft fasciotomy instrument (STSG) segment is expected to hold the largest market share over the forecast period. In this segment, the development of government regulation, and rising funds for private manufacturers for research would drive this market. 

For instance, in April 2021, the US Food and Drug Administration (FDA) granted 510(k) approval to Chemence Medical’s redesigned Exofin fusion skin closure system. Exofin fusion offers a self-adhering, flexible mesh strip and a rapidly curing 2-octyl cyanoacrylate topical adhesive, which covers and seals incisions while also creating an immediate microbial barrier to protect against infections.

Market Geographical Analysis

North America accounted for approximately 42% of the global fasciotomy market share 

North America region is expected to hold the largest market share over the forecast period. The rising incidence of compartment syndrome, technological advancements, and growing awareness among people, in this region, help to propel the market.

For instance, according to clevelandclinic.org, experts estimate that fewer than 10 in every 100,000 people in the U.S. experience acute compartment syndrome each year. However, it’s much more common in people who have some types of bone fractures (broken bones). For example, studies estimate that around 10% of people who break their tibia develop compartment syndrome.

For instance, in February 2020, Bioprinting company T&R Biofab announced a new collaboration agreement with Ethicon Llc., Inc., a Johnson & Johnson Medical Device Company. The partnership aims to develop a 3D bioprinted soft tissue scaffold for wound treatments, reconstructive surgery, and more.

Market Segmentation

By Instrument

• Skin Graft Fasciotomy Instrument (STSG)
• Negative Pressure Wound Treatment Fasciotomy Instrument (NPWT)
• Vascular Ring Technique Fasciotomy Instrument
• Continuous External Tissue Expansion Fasciotomy Instrument (CETE)
• Others 

By Application

• Plantar Fasciitis
• Acute Compartment Syndrome
• Chronic Compartment Syndrome
• Others

By End-User

• Hospitals
• Specialty Clinics
• Ambulatory and Surgery Centers
• Others

By Region

• North America 
• The U.S.
• Canada
• Mexico 
• Europe 
• Germany
• U.K.
• France
• Spain
• Italy
• Rest of Europe 
• South America 
• Brazil
• Argentina
• Rest of South America 
• Asia-Pacific 
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 
• Middle East and Africa

Market Competitive Landscape

The major global players in the global fasciotomy market include Zipline Medical Inc., Stryker Corporation, DermaClose, Terumo Corporation, Merit Medical Systems, Ethicon Llc., Cardinal Health, 3M, Biopro Inc., and Southmedic Inc. among others.

Key Developments

• In June 2022, Advanced Medical Solutions, a specialist in tissue-healing technologies, received FDA 510(k) approval for LiquiBand XL, a new device that can close longer wounds. The device consists of a surgical mesh which is used to close the wound and LiquiBand glue which is used to strengthen the closure and prevent infection.
• In May 2024, SouthMedic, a leading manufacturer of surgical blades, scalpels, and innovative medical devices, announced its partnership with Nano Surgical to become the exclusive master distributor of Lumohs MD no. 3 Lighted Scalpel Handles in Canada.

Why Purchase the Report?

• To visualize the global fasciotomy market segmentation based on type, application, end-user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of global fasciotomy market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in Excel consisting of key products of all the major players.

The global fasciotomy market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies